Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1990 1
1991 3
1992 1
1993 1
1994 2
1995 1
1996 2
1997 2
1998 2
1999 2
2000 1
2004 6
2005 2
2006 2
2007 1
2008 1
2009 1
2011 1
2012 2
2013 4
2014 4
2015 4
2016 2
2017 2
2018 2
2019 3
2020 3
2021 3
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Examination of the shoulder joint.
Leech MT, Hall ST. Leech MT, et al. Among authors: hall st. Med J Aust. 2016 Nov 21;205(10):444-445. doi: 10.5694/mja16.00507. Med J Aust. 2016. PMID: 27852177 No abstract available.
Ethnicity, infection and sudden infant death syndrome.
Blackwell CC, Moscovis SM, Gordon AE, Al Madani OM, Hall ST, Gleeson M, Scott RJ, Roberts-Thomson J, Weir DM, Busuttil A. Blackwell CC, et al. Among authors: hall st. FEMS Immunol Med Microbiol. 2004 Sep 1;42(1):53-65. doi: 10.1016/j.femsim.2004.06.007. FEMS Immunol Med Microbiol. 2004. PMID: 15325398 Free article. Review.
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch.
Razonable RR, O'Horo JC, Hanson SN, Arndt RF, Speicher LL, Seville TA, Hall ST, Pike ML, Heyliger A, Larsen JJ, Ganesh R, Tulledge-Scheitel SM. Razonable RR, et al. Among authors: hall st. J Infect Dis. 2022 Nov 11;226(10):1683-1687. doi: 10.1093/infdis/jiac346. J Infect Dis. 2022. PMID: 36124696 Free PMC article.
Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
O'Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR. O'Horo J, et al. Among authors: hall st. Mayo Clin Proc. 2022 May;97(5):943-950. doi: 10.1016/j.mayocp.2022.02.009. Epub 2022 Feb 23. Mayo Clin Proc. 2022. PMID: 35512884 Free PMC article.
Clinical pharmacology of lacidipine.
Hall ST, Harding SM, Evans GL, Pellegatti M, Rizzini P. Hall ST, et al. J Cardiovasc Pharmacol. 1991;17 Suppl 4:S9-13. J Cardiovasc Pharmacol. 1991. PMID: 1726014 Review.
Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019.
Razonable RR, O'Horo JC, Challener DW, Arndt L, Arndt RF, Clune CG, Culbertson TL, Hall ST, Heyliger A, Jackson TA, Kennedy BD, Larsen J, Hanson SN, Sweeten PW, Tulledge-Scheitel SM, Ganesh R. Razonable RR, et al. Among authors: hall st. Mayo Clin Proc. 2022 Sep;97(9):1641-1648. doi: 10.1016/j.mayocp.2022.06.015. Epub 2022 Jun 23. Mayo Clin Proc. 2022. PMID: 36058578 Free PMC article.
57 results